Stock OMNI BIO PHARMACEUTICAL INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Omni Bio Pharmaceutical Inc OTC Bulletin Board

Equities

Biotechnology & Medical Research

Business Summary

Omni Bio Pharmaceutical, Inc. is a United States-based company that operates as a biopharmaceutical company. The Company is focused on the treatment of immune-mediated inflammatory disease. The Company is providing recombinant version of plasma-derived alpha-1 antitrypsin (p-AAT) platform for intravenous supplementation therapy.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 40,462,602 40,462,602 ( 100.00 %) 0 100.00 %

Company contact information

Omni Bio Pharmaceutical, Inc.

181 West Boardwalk Drive Suite 202

80525, Fort Collins

+

http://omnibiopharma.com
address Omni Bio Pharmaceutical Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.42% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.84% 104B
BIONTECH SE Stock BioNTech SE
-14.15% 22.41B
ARGENX SE Stock argenx SE
-1.05% 22.28B
GENMAB A/S Stock Genmab A/S
-5.29% 19.07B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.16% 17.89B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.99% 14.28B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.24% 12.55B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. OMBP Stock
  4. Stock
  5. Company Omni Bio Pharmaceutical Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW